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ABSTRACT 
The aim of this work is to compare Bayesian Inference for nonlinear models with commonly used 
traditional non-linear regression (NR) algorithms for estimating tracer kinetics in Dynamic 
Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI). The algorithms are compared in 
terms of accuracy, and reproducibility under different initialization settings. Further it is 
investigated how a more robust estimation of tracer kinetics affects cancer diagnosis. The derived 
tracer kinetics from the Bayesian algorithm were validated against traditional NR algorithms (i.e. 
Levenberg-Marquardt, simplex) in terms of accuracy on a digital DCE phantom and in terms of 
goodness-of-fit (Kolmogorov-Smirnov test) on ROI-based concentration time courses from two 
different patient cohorts. The first cohort consisted of 76 men, 20 of whom had significant 
peripheral zone prostate cancer (any cancer-core-length (CCL) with Gleason>3+3 or any-grade 
with CCL>=4mm) following transperineal template prostate mapping biopsy. The second cohort 
consisted of 9 healthy volunteers and 24 patients with head and neck squamous cell carcinoma. 
The diagnostic ability of the derived tracer kinetics was assessed with receiver operating 
characteristic area under curve (ROC AUC) analysis. The Bayesian algorithm accurately 
recovered the ground-truth tracer kinetics for the digital DCE phantom consistently improving 
the Structural Similarity Index (SSIM) across the 50 different initializations compared to NR. For 
optimized initialization, Bayesian did not improve significantly the fitting accuracy on both 
patient cohorts, and it only significantly improved the ve ROC AUC on the HN population from 
ROC AUC=0.56 for the simplex to ROC AUC=0.76.  For both cohorts, the values and the 
diagnostic ability of tracer kinetic parameters estimated with the Bayesian algorithm weren’t 
affected by their initialization. To conclude, the Bayesian algorithm led to a more accurate and 
reproducible quantification of tracer kinetic parameters in DCE-MRI, improving their ROC-AUC 
and decreasing their dependence on initialization settings. 
 
Keywords: DCE analysis, Bayesian Inference for nonlinear model, Prostate cancer, Head and 
Neck 
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1. Introduction 
 Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) is influenced by 
the micro-vascular characteristics of tissue, such as blood flow/volume, surface 
area/permeability of vessel walls, and micro-vascular density. These characteristics are 
associated with the expression of potent cytokines (such as the vascular endothelial growth 
factor) that support the development of tumor vessels. This makes DCE-MRI a valuable 
diagnostic tool in oncology. The purpose of this study is to investigate whether accurate 
quantification of tracer kinetic parameters using the proposed Bayesian Inference for nonlinear 
models can improve cancer diagnosis compared to traditional non-linear regression fitting 
algorithms.  
Quantification of tracer kinetic parameters is affected by field inhomogeneities, 
gradients, SNR of the reconstructed images, and spatiotemporal resolution [1].  Besides 
limitations in acquisition, quantification of tracer kinetic parameters will depend on the 
selection of tracer kinetic model, the accurate estimation of the arterial input function, the 
estimation of the native T1 of the tissue [2] and the selection of fitting algorithm. Heyes et al. 
[3, 4] studied the variation within- and between workstations in the derivation of tracer kinetic 
parameters and reported a 25.1%–74.1% within-subject coefficient of variation. The conclusion 
of these studies is that unless the contrast agent material, the definition of AIF, the image SNR, 
and the fitting process are standardized DCE MRI related parameters will not be reproducible.  
Tracer kinetic models such as the extended Toft model [5] that describe the enhancement 
process are often used to derive quantitative parameters and are increasingly used in diagnostic 
models [6] including computer aided diagnostic (CAD) software [7, 8]. Accurate quantification 
that will be reproducible between different clinical sites is necessary for the widespread of DCE 
based CAD software. This work will investigate how the optimization process itself can affect 
the quantification and the diagnostic ability of the quantified parameters. 
Quantitative DCE parameters are usually extracted by fitting the estimated 
concentration to the measured concentration time intensity course (TIC), using algorithms such 
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as non-linear least squares or the simplex algorithm. These fitting algorithms are prone to hit 
local minima [9] resulting in fitting errors and fitted parameters that depend on their 
initialization. To the best of our knowledge there are no guidelines on how to initialize the tracer 
kinetics, and its clinical site uses its own initialization settings. Consequently there is a clear 
need to develop robust fitting strategies that will not be affected by the initialization of the 
tracer kinetics.  
To overcome these issues, Bayesian inference for nonlinear models were suggested [10, 
11, 12]. Bayesian algorithms can model the noise of the measured concentration of the contrast 
agent and have a theoretical guarantee to converge if run long enough [13]. This work suggests 
a Bayesian inference for nonlinear model algorithm similar to the ones proposed by other 
groups [10, 11, 12] and evaluates its robustness and diagnostic value against the Levenberg–
Marquardt and the simplex algorithms on two separate cohorts of patients: 
i) a cohort of 76 men, 20 of whom had significant prostate cancer in the peripheral zone 
ii) a cohort of 9 healthy volunteers and 24 patients with squamous cell carcinoma. 
The proposed Bayesian inference for nonlinear model algorithm is described in the 
theory section. The robustness value is assessed based on goodness-of-fit, and how robust the 
algorithm is when using different initialization settings of the estimated tracer kinetic 
parameters. Receiver operating characteristic (ROC) analysis is performed on the derived tracer 
kinetics to assess their ability to classify significant cancer.    
 
2. Theory 
2.1 Tracer kinetic Modeling 
A tracer kinetic analysis was performed by fitting the extended Toft [5] (Eq. 1) modelled 
concentration 𝐶(t)  (mmol/L) to the concentration time course 𝐶𝑇𝐼𝐶(t)   (Eq. 2). 
 
𝐶(t) = 𝑣𝑝 ∙ 𝐶𝑎(t) + 𝐾𝑡𝑟𝑎𝑛𝑠 ⋅ ∫ 𝐶𝑎(τ − 𝑡0) ⊗ e
(−
𝐾𝑡𝑟𝑎𝑛𝑠
𝑣𝑒
∙(𝑡−τ))
dτ
t
0
 (1) 
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Where 𝐶𝑎(t) is the arterial input function (mmol/L), 𝑣𝑝is the blood plasma volume fraction, 
𝐾𝑡𝑟𝑎𝑛𝑠 is the transfer constant between plasma and interstitial space (min
-1),𝑣𝑒is the interstitial 
space volume and 𝑡0is the arrival time of the bolus at the tissue (secs). A population arterial 
input function was used [15]. 
The concentration time course was calculated from the image signal intensities 𝑆(t) using the 
approximation Repetition time⪡T1 
 
𝐶𝑇𝐼𝐶 (t) =
1
𝑟1 ∙ 𝑇10 
(
𝑆(t) − 𝑆0
𝑆0
) (2) 
 
Where 𝑟1 is the in-vivo relaxivity (4.51 L mmol
-1 sec-1), 𝑇10 is the native T1 of the tissue 
before contrast agent injection, calculated from a multiple ﬂip angle dataset (sec), and 𝑆0 is the 
average of the acquired images before the injection of the contrast agent. 
 
2.2 Traditional nonlinear regression algorithms 
Tracer kinetic models are fitted with two commonly used non-linear regression algorithms 
i.e. the Levenberg-Marquardt and the simplex algorithm. Levenberg-Marquardt is a least squares 
curve fitting algorithm that is a blend between the Gauss–Newton and the gradient descent 
method. The update rule of the tracer kinetics parameters is: ki+1=ki-(H+λI)-1∇L(ki), where H is 
the Hessian matrix at ki, λ is a regularization parameter and L is the likelihood function to be 
minimized i.e. L(ki)=∑ (𝐶𝑇𝐼𝐶 (t) − 𝐶(t))
2
𝑡  . When the likelihood is decreased λ is also reduced, 
but if the likelihood is increased λ will also be increased to reduce the influence of gradient 
descent. Contrary to other gradient based methods Levenberg-Marquardt is not performing a 
line minimization (where the direction of gradient descent is decided prior to step size 
estimation) hence requires less likelihood evaluations reducing the computational cost.  
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The simplex algorithm is also an iterative procedure but unlike the Levenberg-Marquardt 
does not require derivative information. The algorithm will create a “random” simplex of n+1 
points, where n is the number dimensions (number of tracer kinetic parameters to be estimated). 
The simplex moves iteratively by reflection, expansion or contraction steps trying to find the 
tracer kinetic parameters that minimize the likelihood function. In this work we used a 
constrained variation of the simplex algorithm [16, 17] and a ℓ1-norm in the likelihood function 
to improve robustness [18]. The simplex algorithm is particularly advantageous in cases where 
the gradient of the likelihood functions is hard to calculate. 
 
2.3 Bayesian inference for nonlinear models 
In the proposed Bayesian Inference for nonlinear model algorithm the measured 
concentration 𝐶𝑇𝐼𝐶(t) is modelled using additive Gaussian noise σ
2 and the  tracer kinetic 
parameters, k= {vp, Ktrans, ve, t0} for the extended Tofts model.  
 𝐶𝑇𝐼𝐶(t)~𝐧𝐨𝐫𝐦𝐚𝐥(𝐶(t), σ)   (3) 
The suggested Bayesian algorithm similar to [10, 11, 12] maximizes the posterior probability 
distribution function p(k,σ|CTIC) as a function of k and σ 
 ?̂?, ?̂? = 𝑎𝑟𝑔𝑚𝑎𝑥𝑘,𝜎  𝑝(𝑘, 𝜎|𝐶𝑇𝐼𝐶 )  (4) 
According to the Bayes theorem p(k,σ|CTIC) is given by, 
 
𝑝(𝑘, 𝜎|𝐶𝑇𝐼𝐶 ) = 𝑝(𝑘, 𝜎) ∙ 𝑝(𝐶𝑇𝐼𝐶|𝑘, 𝜎) ∫ 𝑝(𝑘
∗, 𝜎∗) ∙ 𝑝(𝐶𝑇𝐼𝐶|𝑘
∗, 𝜎∗)
𝑘∗,𝜎∗
  (5) 
Where p(CTIC|k,σ) is the likelihood function of CTIC given the tracer kinetic parameters k,  
 
𝑝(𝐶𝑇𝐼𝐶 |𝑘, 𝜎) = (2𝜋𝜎
2)−1exp (−
1
2𝜎2
‖𝐶𝑇𝐼𝐶 (𝒓, 𝑡) − 𝐶(𝒓, 𝑡)‖2
2)  (7) 
and p(k,σ) is the product of the prior probability distribution functions of k and σ, 𝑝(k, σ). 
Prior probability distribution functions reflect our prior knowledge about the k and σ2 
parameters. Similarly to Schmid et al. [10] the subsequent prior distributions are assumed for 
every tracer kinetic parameter: 
 vp follows a Beta distribution, vp~Beta(1,19) [19] reflecting an a priori expected value 
of 0.05. 
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 Ktrans was parameterized as suggested by Schmid et al. [10] as e
θ where θ follows a 
Gaussian distribution θ~Normal(0,1) 
 ve  follows a Beta distribution, ve~ Beta (2,1.5) reflecting an a priori expected value of 
0.57 
 t0 follows a uniform random distribution unif (injection time,injection time+40).  
 σ2 follows an uninformative Inverse Gamma distribution IG(10-4, 10-4)  
The integral ∫ 𝑝(𝑘∗, 𝜎∗) ∙ 𝑝(𝑦|𝑘∗, 𝜎∗)𝑘∗,𝜎∗  is estimated with the Metropolis–Hastings algorithm.  
 
3. Materials and methods 
3.1 Generate Simulated DCE data 
 The DCE simulation used is similar to the one published from our group in Dikaios et 
al. (2014) [20]. A normal volunteer underwent a fast gradient echo DCE-MRI protocol (flip 
angle α=10o, repetition time TR=2.3 msecs). A T1-weighted abdominal image was acquired 
without contrast injection. The first time-frame was manually segmented into: liver, bowel, right 
and left heart, aorta, portal vein. Such segmentation was used as a map to simulate contrast 
enhancement using the extended Tofts model or the dual input function Orton model for the 
liver. Ground truth parametric maps i.e. native T10 (range 382-1932 msecs), vp (range 0-1), ve 
(range 0-1), and Ktrans  (range 0-1.38 min
-1) were used to simulate fifty DCE images with 
temporal resolution 3 secs using the spoiled gradient echo model.  
 
𝑆(𝑡) = 𝜌
sin(𝛼) ∙ (1 − exp (−
𝑇𝑅
𝑇1(𝑡; 𝑘)
))
1 − cos (𝛼) ∙ exp (−
𝑇𝑅
𝑇1(𝑡; 𝑘)
)
  (8) 
Where  is the proton density image, and was calculated analytically using Eq. 8 from the T1-
weighted abdominal image without contrast injection and the graund truth T10 maps.  
DCE images were transformed to (k, t)-space with fast Fourier transformation where noise was 
added. The noise of complex valued (k, t)-space MR data can be reasonably modelled by an 
additive white Gaussian distribution on both real and imaginary components (independent and 
identically distributed random variables). Simulated DCE data were generated for 2 different 
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noise levels , one corresponding to the average SNR before contrast injection of prostate T1w  
images (SNR~9.2, noise level=2500) and a separate one corresponding to the average SNR 
before contrast injection of neck T1w images (SNR~15.1, noise level=800). The SNRs were 
calculated as described in Dikaios et al. [21]. 
 
3.2 Patient populations 
Institutional review board (IRB) approval for the study was obtained. The requirement 
for consent was waived for use of images acquired in routine clinical practice (prostate 
peripheral zone population) and obtained from all patients undergoing imaging as part of a 
separate clinical trial (head and neck population). 
 
Prostate population 
The prostate population consisted of men with clinically suspected prostate cancer (elevated 
prostate specific antigen (PSA) ± abnormal digital rectal examination ± family history of 
prostate cancer ± urinary symptoms,) undergoing prostatic multiparametric MRI (mp-MRI: T2 
weighted, diffusion weighted and DCE imaging) prior to template-prostate-mapping (TPM) 
biopsies as part of standard of care at our institution. In total 76 men (mean age 63 years, range 
45-79) with a mean prostate specific antigen of 7.8 ng/ml (range 1.2-20 ng/ml) and a mean 
prostate gland volume of 48.2 ml (range 23-137 ml) were included from 06/2007 to 03/2011. 
Twenty of the 76 men had histologically verified clinically significant peripheral zone prostate 
cancer. 
Imaging was performed using a 1.5T magnet (Avanto, Siemens, Erlangen, Germany) 
with a pelvic phased array coil. The contrast media was Dotarem with an application dose 0.2 
mL/Kgr.  Prior to imaging, 0.2 mg/kg (maximum 20 mg) of spasmolytic (Buscopan; Boehringer 
Ingelheim, Ingelheim, Germany) was administered intravenously to reduce peristalsis. DCE-
MRI was performed with a T1 weighted volumetric FLASH sequence with TR/TE 5.61/2.5 ms, 
flip angle 15o, 384384 matrix dimensions, field of view 269 mm, slice thickness 3 mm, 26 
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reconstructed slices, temporal resolution of 16 seconds, and number of time points 35.  
For the purpose of this study and to match with the target performance of mp-MRI as defined by 
recent consensus [24]; histopathologists identified all locations with clinically significant cancer 
based on volume assessment (0.2 ml) estimated by the cancer core length (CCL)>= 4 mm 
and/or the presence of Gleason pattern 4 disease [25]. Small volume (<0.2 ml) and low grade 
(<=Gleason 3+3) tumour was identified as clinically insignificant cancer.  
An experienced radiologist (with 10 years of mp-MRI experience, reporting 500 mp-
MRI prostate scans/year) and using the TPM biopsy histology as a guide, carefully matched the 
histopathology template to the mp-MRI; and contoured a region of interest (ROI) on early 
contrast enhanced T1 weighted images at the single largest histologically confirmed significant 
cancer site. For patients where the entire prostate was benign or contained only insignificant 
cancer, the radiologist contoured a 1-cm2 ROI at a confirmed benign location within the PZ. 
 
Head and Neck population 
Twenty-four consecutive patients (mean age 60 years, standard deviation 9 years, range 44 to 80 
years) satisfying inclusion criteria of histologically confirmed head and neck SCC with cervical 
nodal metastatic disease at pre-therapy staging, and 9 normal volunteers (mean age 48 years, 
standard deviation 16 years, range 20 to 75 years) were recruited between March 2010 and May 
2012. All patients underwent contrast enhanced neck computed tomography (CECT), 
anatomical MRI and neck ultrasound as part of routine pre-treatment staging; and were 
consented for additional DCE MRI of the neck for research purposes.  
All MRI studies were acquired using a 1.5T Siemens Avanto (Siemens, Erlangen, Germany) 
magnet with the manufacturer’s carotid coils. The contrast media was Dotarem with an 
application dose 0.2 mL/Kgr. DCE-MRI was performed with a T1 weighted volumetric FLASH 
sequence with TR/TE 2.3/1.0 ms, flip angle 10o, 256256 matrix dimensions, field of view 269 
mm, slice thickness 4 mm, temporal resolution of 3 seconds, and number of time points 50.  
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The reference standard was established by experienced head and neck radiologists (with 8 years 
and 24 years of head and neck experience respectively) through review of all CT and anatomical 
MRI, and performance of ultrasound evaluation of the neck in all patients. Cervical nodes were 
assessed as per the Union for International Cancer Control (UICC): Tumor nodal-metastasis 
(TNM) classification of malignant tumours [26]. Equivocal nodes were sampled at the time of 
ultrasound by fine needle aspiration (FNA) and classified by in-room cytology.  
 
3.3 Optimization details of the fitting algorithms 
Fitting algorithms were implemented with in-house–developed software in MATLAB 
(The Mathworks Inc, Natick, MA). The tracer kinetic parameters for the simplex, the 
Levenberg-Marquardt and the Bayesian inference for nonlinear model were initialized as vp
0= 
0.05, Ktrans
0= 0.4 min-1, ve
0= 0.5 for both the simplex and the Levenberg-Marquardt. The 
constraints of the tracer kinetic parameters were: 𝑣𝑝 ∈ [0,1], 𝐾𝑡𝑟𝑎𝑛𝑠 ∈ [0,2.7] 𝑚𝑖𝑛
−1, 𝑣𝑒 ∈
[0,1], 𝑡0 ∈ [𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒, 𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒 + 40 𝑠𝑒𝑐𝑠]. Onset time was initialized with the 
time point the contrast agent was administered.  
The simplex, the Levenberg-Marquardt and the Bayesian inference for nonlinear model 
were run using multiple initialisations of the tracer kinetic parameters. In addition to the 
aforementioned initialization, 49 different initialisations were also generated (50 initializations 
in total) using uniform distributions supported within intervals as described by the following 
formulas: vp
0= unif (0, 0.2), Ktrans
0= unif (0.3, 1.0), ve
0= unif (0.3, 0.6). 
For the proposed Bayesian inference for nonlinear model the total number of iterations 
was 500, burn-in iterations were 300, thinning equal to 5, and tune iteration (number of 
iterations for tuning) was 67. 
 
3.4 Statistical analysis 
Statistical analysis was performed using SPSS (SPSS Base 20.0 for Windows. SPSS 
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Inc., Chicago IL). The same statistical analysis was performed for both the head and neck and 
PZ prostate population. 
A Mann–Whitney U test (MWU sig) was performed to compare the median values of 
the tracer kinetic parameters between normal and cancer ROIs. The goodness-of-fits were 
assessed with the Kolmogorov-Smirnov (KS) test statistic. 
Separate univariate logistic regression models were built for the tracer kinetic 
parameters derived using the simplex and the Bayesian algorithms. The ability of individual 
tracer kinetic parameters to classify cancer was assessed by receiver operator characteristic 
(ROC) area under curve (AUC) analysis.  
Leave-one-out analysis [21] was used for internal validation of predictive models. One 
case (out of the total patient population) was excluded, and a model generated from the 
remainder of the cases. The model was then tested on the excluded case and a predictive 
probability calculated. The process was repeated for all cases, excluding successive cases in turn 
allowing calculation of a predictive probability per case. An ROC (LOO ROC) was then created 
using the derived predictive probabilities. ROC curves were compared using the significance 
test suggested by Hanley and McNeil [27]. 
 
4. Results 
4.1 Simulated DCE data 
Table 1 demonstrates the similarity in terms of Structural SIMilarity (SSIM) index of 
the estimated tracer kinetic maps estimated with the simplex, the Levenberg Marquardt and the 
Bayesian inference for nonlinear model to the ground truth tracer kinetic maps. Results are 
shown for two different noise realizations, one corresponding to the SNR of prostate T1w 
images (~9.2) before contrast injection and one corresponding to the SNR of neck T1w images 
(~15) before contrast injection. The tracer kinetic maps estimated with the Bayesian algorithm 
have substantially higher SSIM and are less affected from the different initializations of the 
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tracer kinetic parameters (lower interquartile range across the 50 different initializations). The 
simplex algorithm has similar performance to the Levenberg-Marquardt (LM), with marginally 
higher SSIM. Fig. 1 provides a visual comparison between the tracer kinetics maps estimated 
with the simplex and the Bayesian algorithm. 
 
 
Fig. 1  
Parametric maps (vp, Ktrans, ve, t0) estimated with pixel-by-pixel fitting of the simulated DCE 
images with SNR=9.2 using the simplex and the Bayesian inference for nonlinear model. Ground 
truth tracer kinetics maps are shown at the top row. 
 
Table 1  
SIMilarity (SSIM) index between the parametric maps (vp, Ktrans, ve, t0) estimated with pixel-by-
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pixel fitting (using the simplex, the Levenberg Marquardt and the Bayesian algorithms) and the 
ground truth parametric maps of simulated DCE data. Results are shown for different noise 
realizations with SNR=9.2 (prostate T1w images) and SNR=15 (neck T1w images). Median and 
Interquartile range (iQR) of SSIM were calculated across the 50 different initializations for each 
method. 
 Median (iQR) vp Ktrans  ve t0 
SNR=9.2 
simplex 0.90 (0.17) 0.69 (0.13) 0.81 (0.14) 0.70 (0.12) 
LM 0.89 (0.17) 0.69 (0.14) 0.80 (0.15) 0.68 (0.14) 
Bayesian 0.92 (0.02) 0.81 (0.01) 0.84 (0.02) 0.76 (0.01) 
SNR=15 
simplex 0.95 (0.11) 0.81 (0.10) 0.87 (0.08) 0.79 (0.09) 
LM 0.95 (0.11) 0.81 (0.10) 0.86 (0.08) 0.79 (0.09) 
Bayesian 0.98 (<0.01) 0.91 (<0.01) 0.93 (0.01) 0.86 (0.01) 
 
 
4.2 Prostate population  
Multiple initialisations – Robustness of evaluated algorithms 
The simplex, the Levenberg-Marquardt and the Bayesian algorithm were all run with the same 
50 different initializations, Fig. 2 shows the KS test statistic (across the 76 mean ROI TICs of 
the PZ prostate population) for each initialization. The interquartile range of the medians was 
0.019 for the simplex algorithm, 0.018 for the Levenberg-Marquardt algorithm and 0.002 for the 
Bayesian algorithm. The simplex algorithm had consistently better goodness-of-fit than the 
Levenberg-Marquardt; hence hereafter the Levenberg-Marquardt was excluded from the 
comparison. 
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Fig. 2 
Plot of the median KS statistic test (median KS statistic test across the 76 mean ROI PZ prostate 
TICs) across the 50 different initializations for the Levenberg-Marquardt, the simplex and the 
Bayesian algorithms. The interquartile range (iQR) of the median KS statistic test is 0.019 for the 
Levenberg-Marquardt, 0.018 for the simplex and 0.002 for the Bayesian.  
 
Univariate ROC analysis 
Table 2 shows the ROC analysis of the tracer kinetic parameters estimated with the simplex and 
the Bayesian algorithms using the optimum tracer kinetic initialization in terms of goodness-of-
fit.  Ktrans was the best classifier of PZ prostate cancer for both the simplex and the Bayesian 
algorithm. According to the score test only Ktrans estimated with the Bayesian algorithm could 
significantly discriminate PZ prostate cancer (p=0.02) (Table 2). However following a 
significance test between ROC curves, the AUC of Ktrans estimated with the Bayesian algorithm 
(shown in Table 2) was not significantly better.  
The simplex and the Bayesian algorithms were run with different initializations as 
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described in section 3.3 and the ROC AUC were estimated per tracer kinetic parameter for each 
initialization. The median (interquartile range) ROC AUC across the 50 different initializations 
were vp:0.55 (0.05), Ktrans:0.57 (0.14), and ve:0.56 (0.05) for the simplex algorithm and vp:0.63 
(0.02), Ktrans:0.67 (0.02), and ve:0.56 (0.01) for the Bayesian algorithm. The median ROC AUC 
values for vp and Ktrans between the simplex and the Bayesian were significantly different. 
 
Table 2 
Score test and univariate ROC analysis of the tracer kinetic parameters derived with the simplex 
and the Bayesian algorithms (using the optimum tracer kinetic initialization in terms of goodness-
of-fit) performed on the ROI-based TIC from the whole PZ population and following LOO 
analysis. 
 
 
 
 
 
 
 
Comparison of tracer kinetic parameters between PZ prostate cancer/benign ROIs 
Parametric maps of a PZ prostate cancer patient estimated with the simplex and the Bayesian 
algorithms are illustrated in Fig. 3. The modelled concentration C(t) is fitted to the mean 
concentration TIC along the PZ prostate cancer ROI CTIC(t) (Fig. 3).  In Fig. 3, while vp values 
estimated from the cancer ROI TIC are almost zero for the simplex algorithm, following pixel-
by-pixel fitting the cancer area in the vp seems to be slightly higher than zero. Tracer kinetic 
parameters estimated by fitting mean ROI TICs will not necessarily correlate with tracer kinetic 
parameters estimated by pixel-by-pixel fitting. Taking the mean of an ROI and propagating it in 
time will generate a “smooth” profile, resulting in an approximated time-intensity curve. Ideally 
    score (p-value) ROC AUC (CI) LOO ROC AUC (CI) 
simplex 
vp 0.21 (0.65) 0.61 (0.47-0.76) 0.22 (0.11-0.33) 
Ktrans 3.22 (0.07) 0.64 (0.50-0.78) 0.57 (0.41-0.72) 
ve 0.69 (0.41) 0.54 (0.40-0.68) 0.41 (0.28-0.54) 
 
 
  
 
Bayesian 
vp 2.31 (0.13) 0.58 (0.43-0.74) 0.48 (0.32-0.65) 
Ktrans 5.46 (0.02) 0.67 (0.54-0.81) 0.63 (0.50-0.77) 
ve 0.75 (0.39) 0.56 (0.41-0.71) 0.44 (0.30-0.58) 
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pixel-by-pixel fitting needs to be performed, but because it is more computationally demanding 
many clinical papers resort to mean ROI TIC fitting. 
Following MWU test, none of the tracer kinetic parameters estimated with the Bayesian 
algorithm were significantly different from the ones estimated with the simplex algorithm for 
either the benign or the cancer ROIs (Fig. 4). 
Fig. 3 
Tracer kinetic maps (vp, Ktrans, ve) estimated with pixel-by-pixel fitting using the simplex and the 
Bayesian algorithms for a PZ prostate cancer patient. A plot of the mean ROI concentration TIC 
𝐶𝑇𝐼𝐶(t) and the fitted to curve using the simplex and the Bayesian algorithms is also shown.  
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Fig. 4  
Boxplot diagram of the tracer kinetic parameters derived with the simplex and the proposed 
Bayesian algorithm, performed separately for the normal and cancer PZ prostate ROI based TIC. 
The terms in brackets refer to the median value (interquartile range) of the estimated tracer kinetic 
parameters.  
 
4.3 Head and Neck population    
Multiple initialisations – Robustness of evaluated algorithms 
The simplex, the Levenberg-Marquardt and the Bayesian algorithms were all run with the 
same 50 different initializations, Fig. 5 shows the median KS statistic test (across the 33 mean 
ROI TICs of the head and neck patients and volunteers) for each initialization. The interquartile 
range of the medians was 0.0083 for the simplex algorithm, 0.010 for the Levenberg-Marquardt 
algorithm and 0.0021 for the Bayesian algorithm. Simplex algorithm had consistently better 
goodness-of-fit than the Levenberg-Marquardt; hence from hereafter the Levenberg-Marquardt 
was excluded from the comparison. 
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Fig. 5  
Plot of the median KS statistic test (median KS statistic test across the 33 mean ROI head and 
neck TICs) across the 50 different initializations for the simplex and the Bayesian algorithms. 
The interquartile range (iQR) of the median KS statistic test is 0.010 for the Levenberg-
Marquardt, 0.0083 for the simplex and 0.0021 for the Bayesian algorithm.  
 
Univariate ROC analysis 
Table 3 shows the ROC analysis of the tracer kinetic parameters estimated with the 
simplex and the Bayesian algorithms using the optimum tracer kinetic initialization in terms of 
goodness-of-fit.  Ktrans was the best classifier of head and neck metastatic patients for both the 
simplex and the Bayesian algorithms. According to the score test, for the simplex algorithm only 
Ktrans could significantly classify metastatic patients, whereas for the Bayesian both Ktrans and ve 
were significant classifiers (table 3). 
Following a significance test between ROC curves, the AUC (on the original population or 
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following LOO analysis) of Ktrans, estimated with the Bayesian algorithm, was not significantly 
better. Significant difference was only found for the ve AUC between the simplex and the 
Bayesian algorithms (table 3).  
The simplex and the Bayesian algorithms were run with different initializations as 
described in section 3.3 and the ROC AUC were estimated per tracer kinetic parameter for each 
initialization. ROC AUC were estimated per tracer kinetic parameter for each initialization. The 
median (interquartile range) ROC AUC across the 50 different initializations were vp: 0.54 (0.14), 
Ktrans:0.76 (0.13), and ve:0.56 (0.15) for the simplex algorithm and vp:0.59 (0.03), Ktrans:0.81 
(0.01), and ve:0.79 (0.02) for the Bayesian algorithm. The median ROC AUC values for ve 
between the simplex and the Bayesian were significantly different. 
 
Table 3  
Score test and univariate ROC analysis of the tracer kinetic parameters derived with the simplex 
and the Bayesian algorithms (using the optimum tracer kinetic initialization in terms of goodness-
of-fit) performed on the ROI-based TIC from the whole head and neck patient population and 
following LOO analysis. Asterisk (*) denotes the cases where the tracer kinetic parameter 
estimated with the Bayesian algorithm is significantly different from the corresponding one 
derived with the simplex algorithm. 
    score (p-value) ROC AUC (CI) LOO ROC AUC (CI) 
simplex 
vp 0.12 (0.73) 0.56 (0.33-0.79) 0.30 (0.13-0.48) 
Ktrans 5.43 (0.02) 0.74 (0.58-0.90) 0.66 (0.43-0.89) 
ve
* 0.54 (0.49) 0.56 (0.34-0.77) 0.31 (0.15-0.50) 
 
 
   
Bayesian 
vp 1.05 (0.31) 0.58 (0.35-0.80) 0.51 (0.31-0.72) 
Ktrans 6.37 (0.01) 0.80 (0.64-0.94) 0.75 (0.57-0.92) 
ve
* 4.76 (0.03) 0.76 (0.60-0.93) 0.70 (0.52-0.89) 
 
 
Comparison of tracer kinetic parameters between metastatic/benign ROIs 
Parametric maps of a head and neck metastatic patient estimated with the simplex and the 
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Bayesian algorithms are illustrated in Fig. 6. Fitting the estimated concentration C(t) to the mean 
ROI concentration TIC along the head and neck metastatic nodes CTIC (t) is also shown in Fig. 6.   
Following MWU test all the tracer kinetic parameters estimated with the Bayesian 
algorithm were significantly different from the ones estimated with the simplex algorithm for both 
the benign and the cancer ROIs (Fig. 7). 
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Parametric tracer kinetic maps (vp, Ktrans, ve) estimated with pixel-by-pixel fitting using the 
simplex and the Bayesian algorithms for a head and neck patient with a metastasis. A plot of the 
mean ROI concentration TIC 𝐶𝑇𝐼𝐶 (t) and the fitted curve using the simplex and the Bayesian 
algorithms is also shown. 
 
Fig. 7 
Box-plot diagram of the tracer kinetic parameters derived with the simplex and the proposed 
Bayesian algorithms, performed separately for the benign and metastatic neck node ROIs. The 
terms in brackets refer to the median value (interquartile range) of the estimated tracer kinetic 
parameters. Asterisk (*) denotes significant difference (p<0.05) between the simplex and 
Bayesian algorithms.  
 
5. Discussion 
This works aims to investigate the diagnostic benefits of using Bayesian algorithms for 
the derivation of tracer kinetic parameters in DCE-MRI. The proposed Bayesian algorithm is 
compared against traditional non-linear regression algorithms (i.e. Levenberg-Marquardt and 
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simplex) in terms of accuracy, reproducibility under different initialization settings and ability to 
classify cancer.  
The simplex algorithm had consistently marginally higher SSIM with the ground truth 
kinetics of the simulated DCE phantom and better goodness-of-fit for the ROI-based TIC of both 
populations than the Levenberg–Marquardt, which could be attributed to its convergence 
properties [17]. Unlike the Levenberg–Marquardt, the simplex algorithm does not use gradients, 
which provides some resilience to noise and local minima.  Nonetheless both the Levenberg–
Marquardt and the simplex algorithm are prone to hit local minima, which is evident from our 
data. Re-initialization could reduce the risk to stop at a local minima. However to the best of our 
knowledge there is no optimum way on how to re-initialize the algorithms for DCE-MRI tracer 
kinetic quantification. Alternatively this work proposes a Bayesian inference for nonlinear model 
algorithm, which is shown to be resilient to local minima. Specifically, when running the proposed 
Bayesian for different initializations we found that 
i. The SSIM with the ground truth tracer kinetic maps for the Bayesian algorithm was 
consistently higher than for the non-linear regression algorithms for all initializations. 
ii. The goodness-of-fit (KS statistic test) for the Bayesian algorithm was almost constant 
and consistently lower than the non-linear regression algorithms for all initializations and 
for both populations. 
iii. The ROC AUC of the tracer kinetic parameters estimated with the Bayesian 
algorithms have an interquartile range across the different initializations up to 0.03, 
whereas for the simplex algorithm the interquartile range is up to 0.14 (PZ prostate 
population) and 0.15 (head and neck population). 
Tracer kinetic parameters estimated with the proposed Bayesian algorithm had higher 
classification ability for both PZ prostate and head and neck cancer. Tracer kinetic parameters 
estimated with the simplex algorithm that could not significantly classify disease, when estimated 
with the proposed Bayesian algorithm were significant classifiers of PZ prostate cancer (i.e. Ktrans) 
and metastatic head and neck cancer (i.e. ve). However the ROC AUC improvement achieved 
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with the Bayesian algorithm was not significant for the PZ prostate cancer. For the head and neck 
metastasis only the ROC AUC improvement for ve was significant. 
 
Bayesian inference for nonlinear model algorithms have been proposed before in the 
literature [10, 11, 12] to estimate unbiased quantitative tracer kinetic parameters. The proposed 
scheme is similar to the one suggested by Schmid et al. [10], the main difference is on the 
estimation of the onset time. The accuracy of the estimated tracer kinetic parameters will depend 
on the arrival time of the contrast agent to the tissue (onset time) [28]. Schmid et al. [10] calculated 
the onset time as the minimum time t*, for which the contrast concentration significantly exceeds 
zero minus C(t*)/tC(t*). For the simulated DCE phantom with SNR=9.2, the SSIM index of the 
onset time calculated with the method of Schmid et al. [10] is 0.5754, whereas for the proposed 
Bayesian algorithm the respective SSIM is 0.76 (Table 1). This affected the estimation of the 
tracer kinetic parameters, but if the same onset time was used the Bayesian method suggested by 
Schmid et al. [10] has similar performance with the one proposed in this work. This is expected 
since both use the Metropolis–Hastings Markov chain Monte Carlo (MCMC) method and similar 
prior information. Their only difference is that we parameterized the posterior probability 
distribution function p(k,σ|CTIC) with ve to optimize EES volume directly instead of calculating it 
via kep (ve=Ktrans/kep) [7]. 
 
6. Limitations 
For the PZ prostate population, we were reliant upon visual matching of the Barzell zone histology 
on TPM with the ROIs on the mp-MRI. Therefore, results may be influenced by mis-registration 
errors. Although no biopsy is free from sampling error [29] we used TPM to address as much of 
the systematic error inherent to transrectal ultrasound (TRUS) guided biopsy as possible [29, 30].  
For the head and neck population there was a relatively small sample size. We took great care to 
be certain about positive and negative disease status within individual nodes by recruiting patients 
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with N2/3 disease confirmed by CT, MRI and US ± FNA.  
 
7. Conclusions  
DCE MRI tracer kinetic parameters are increasingly used in clinical practice; their diagnostic 
ability will depend on their accurate and reproducible quantification.  The proposed Bayesian 
inference for nonlinear model algorithm has been shown in this work to improve the diagnostic 
ability compared to the simplex algorithm and was robust when different initializations of the 
tracer kinetic parameters were used. These assets of the algorithm are essential to train and 
validate robust CAD software based on DCE-MRI that could be used between different sites. The 
performance of the Bayesian algorithm was consistent on two different populations, acquired with 
different settings. 
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